Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
Henk-Jan Westeneng, Thomas P. A. Debray, Anne E Visser, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 5, pp. 423-433
Open Access | Times Cited: 443

Showing 1-25 of 443 citing articles:

Amyotrophic lateral sclerosis: a clinical review
Pegah Masrori, Philip Van Damme
European Journal of Neurology (2020) Vol. 27, Iss. 10, pp. 1918-1929
Open Access | Times Cited: 808
Amyotrophic lateral sclerosis
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 562
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases
Monika A. Myszczynska, Poojitha N. Ojamies, Alix M.B. Lacoste, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 8, pp. 440-456
Closed Access | Times Cited: 445
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Manoj K. Jaiswal
Medicinal Research Reviews (2018) Vol. 39, Iss. 2, pp. 733-748
Closed Access | Times Cited: 376
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
Stephen A. Goutman, Orla Hardiman, Ammar Al‐Chalabi, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 5, pp. 480-493
Open Access | Times Cited: 288
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Richard J. Mead, Ning Shan, H. Joseph Reiser, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 185-212
Open Access | Times Cited: 269
Improving clinical trial outcomes in amyotrophic lateral sclerosis
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, et al.
Nature Reviews Neurology (2020) Vol. 17, Iss. 2, pp. 104-118
Open Access | Times Cited: 231
Personalised virtual brain models in epilepsy
Viktor Jirsa, Huifang Wang, Paul Triebkorn, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 443-454
Open Access | Times Cited: 84
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 59
Molecular subtypes of ALS are associated with differences in patient prognosis
Jarrett Eshima, Samantha O’Connor, Ethan Marschall, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Neuroimaging correlates of domain-specific cognitive deficits in amyotrophic lateral sclerosis
Harold H G Tan, Abram D. Nitert, Kevin van Veenhuijzen, et al.
NeuroImage Clinical (2025) Vol. 45, pp. 103749-103749
Open Access | Times Cited: 2
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
Leonard H. van den Berg, Eric J. Sorenson, Gary Gronseth, et al.
Neurology (2019) Vol. 92, Iss. 14
Open Access | Times Cited: 124
Diagnostic and Prognostic Performance of Neurofilaments in ALS
Koen Poesen, Philip Van Damme
Frontiers in Neurology (2019) Vol. 9
Open Access | Times Cited: 121
A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis
David Devos, Caroline Moreau, Maéva Kyheng, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 118
Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions
Vincent Grollemund, Pierre‐François Pradat, Giorgia Querin, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 116
Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis
Danielle Richards, John A. Morren, Erik P. Pioro
Journal of the Neurological Sciences (2020) Vol. 417, pp. 117054-117054
Open Access | Times Cited: 116
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
Benjamin Gille, Maxim De Schaepdryver, Janne Goossens, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 3, pp. 291-304
Open Access | Times Cited: 104
Disease-modifying therapies in amyotrophic lateral sclerosis
Adriano Chiò, Letizia Mazzini, Gabriele Mora
Neuropharmacology (2020) Vol. 167, pp. 107986-107986
Closed Access | Times Cited: 98
Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis
Iddo Magen, Nancy‐Sarah Yacovzada, Eran Yanowski, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 11, pp. 1534-1541
Open Access | Times Cited: 93
Altered perivascular fibroblast activity precedes ALS disease onset
Anna Månberg, Nathan Skene, Folkert Sanders, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 640-646
Open Access | Times Cited: 90
CSF chitinase proteins in amyotrophic lateral sclerosis
Alexander G. Thompson, Elizabeth Gray, Alexander Bampton, et al.
Journal of Neurology Neurosurgery & Psychiatry (2019) Vol. 90, Iss. 11, pp. 1215-1220
Open Access | Times Cited: 88
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
Rishi K. Gupta, Claire Calderwood, Alexei Yavlinsky, et al.
Nature Medicine (2020) Vol. 26, Iss. 12, pp. 1941-1949
Open Access | Times Cited: 86
Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
Ruben P. A. van Eijk, Henk-Jan Westeneng, Stavros Nikolakopoulos, et al.
Neurology (2019) Vol. 92, Iss. 5
Open Access | Times Cited: 84
Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS
Rangariroyashe H. Chipika, Eoin Finegan, Stacey Li Hi Shing, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 84
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
Namita Goyal, James Berry, Anthony J. Windebank, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 2, pp. 156-166
Open Access | Times Cited: 81
Page 1 - Next Page

Scroll to top